| 2009 |
PTCD1 is a mitochondrial matrix protein that associates with leucine tRNAs and precursor RNAs containing leucine tRNAs; knockdown increases leucine tRNA and precursor RNA abundance while overexpression reduces them, identifying PTCD1 as a negative regulator of mitochondrial leucine tRNA levels and hence mitochondrial translation. |
Subcellular fractionation (mitochondrial matrix localization), RNA immunoprecipitation, RNAi knockdown and overexpression in 143B cells with RT-qPCR and Western blot readouts, Complex IV activity assay |
Nucleic acids research |
High |
19651879
|
| 2011 |
PTCD1 affects the 3′ end processing of mitochondrial tRNAs (distinct from MRPP1/MRPP3 which process 5′ ends and ELAC2 which also affects 3′ ends), as determined by deep sequencing of mitochondrial transcript ends in cells with altered PTCD1 levels. |
Deep sequencing (RNA-seq) of 5′ and 3′ ends of mitochondrial transcripts in cells with manipulated PTCD1 levels |
Cell cycle (Georgetown, Tex.) |
Medium |
21857155
|
| 2014 |
PTCD1 protein levels are regulated post-transcriptionally during leucine starvation: leucine deprivation increases PTCD1 mRNA but decreases PTCD1 protein, and RNAi-mediated knockdown of PTCD1 stabilises mitochondrial leucine tRNAs (tRNA-Leu(CUN) and tRNA-Leu(UUR)), suggesting PTCD1 protein concentration modulates leucine tRNA stability in response to amino acid availability. |
RT-qPCR, Western blot, RNAi knockdown in HepG2 cells under leucine starvation conditions |
Amino acids |
Medium |
24710704
|
| 2018 |
PTCD1 binds 16S rRNA and is essential for its stability, pseudouridylation, and correct biogenesis of the mitochondrial large ribosomal subunit (mt-LSU); CRISPR/Cas9 knockout in heart and skeletal muscle causes loss of mt-LSU assembly, abolishes mitochondrial translation, and leads to severe cardiomyopathy and premature death. Loss of PTCD1 also triggers retrograde signalling via transcriptional activation of the mTOR pathway and upregulation of cytoplasmic protein synthesis. |
CRISPR/Cas9 tissue-specific knockout mouse, transcriptome-wide RNA analysis, ribosome profiling/assembly assays, pseudouridylation mapping, mitochondrial translation assays, mTOR pathway analysis |
Cell reports |
High |
29617655
|
| 2019 |
PTCD1 is required for normal mitochondrial 16S rRNA levels and proper assembly of the mitochondrial ribosome, mitochondrial translation, and electron transport chain assembly; loss of PTCD1 impairs oxidative phosphorylation, forcing cells to rely on glycolysis. In neurons, reduced PTCD1 expression lowers ATP levels and reduces spontaneous synaptic activity. An AD-associated PTCD1 variant fails to sustain energy production under metabolic stress. |
Knockdown/knockout cell lines, mitochondrial rRNA quantification, ribosome assembly assays, mitochondrial translation assay, oxygen consumption measurement, metabolic flux analysis, primary neuron electrophysiology |
The Journal of neuroscience |
High |
30948477
|
| 2020 |
Mitochondrial FOXM1 directly binds PTCD1 protein and increases its levels, thereby inhibiting leucine-rich electron transport chain complexes and reducing mitochondrial respiration; this was shown using site-directed mutagenesis to restrict FOXM1 to mitochondria and co-immunoprecipitation/binding assays. |
Site-directed mutagenesis of FOXM1 (mitochondria-targeting vs. nuclear), co-immunoprecipitation of FOXM1 with PTCD1, mitochondrial respiration and ETC activity assays |
Molecular biology of the cell |
Medium |
32348194
|
| 2020 |
Haploinsufficient Ptcd1 mice (reduced mitochondrial protein synthesis) fed a high-fat diet are protected from excessive weight gain through Akt-stimulated upregulation of mitochondrial biogenesis, resulting in improved glucose and insulin tolerance and reduced hepatic lipid accumulation, but inflammation of white adipose tissue and early skeletal muscle fibrosis are exacerbated; demonstrating tissue-specific recovery of OXPHOS via Akt/mitochondrial stress response. |
Haploinsufficient Ptcd1 mouse model, high-fat diet feeding, glucose and insulin tolerance tests, histology, mitochondrial biogenesis assays, Akt pathway analysis |
Aging |
Medium |
33024056
|
| 2026 |
ZBTB16 transcriptionally activates PTCD1 by binding its promoter (confirmed by dual-luciferase assay); knockdown of PTCD1 abolishes ZBTB16's protective effects on Schwann cell differentiation and mitochondrial function, placing PTCD1 downstream of ZBTB16 in a pathway maintaining mitochondrial integrity in Schwann cells. |
Dual-luciferase reporter assay (ZBTB16 binding to PTCD1 promoter), PTCD1 siRNA knockdown in high-glucose-treated Schwann cells, mitochondrial function assays |
FASEB journal |
Medium |
41482827
|